Anthropic launched Claude Science — an AI workbench for researchers — and announced it will run its own drug-discovery programs for neglected diseases, aiming to compress R&D tenfold. What it...
Recent research highlights how neutrophil extracellular traps (NETs) drive chronic inflammation and vascular aging, with NET inhibitors like DNase I and PAD4 antagonists showing potential in reducing ...
Artificial intelligence is accelerating drug discovery for rare diseases, reducing costs by up to 50% and shortening timelines, enabling bespoke therapies and improving healthcare equity globally. AI ...
Breakthrough cubosome technology enhances bioavailability of curcumin and berberine, offering precise pancreatic beta-cell targeting and improved glycemic control in preclinical trials, challenging tr...
Recent advancements in herbal cubosome technology offer a promising, cost-effective alternative to traditional arthritis treatments, with significant clinical efficacy and minimal side effects. Herbal...
Recent studies show herbal cubosomes enhance arthritis drug delivery, reducing side effects and improving efficacy, with clinical trials expected soon. Herbal cubosomes offer a breakthrough in arthrit...
Nanotechnology breakthrough combines herbal medicine with cubosome delivery, showing 50% greater pain reduction than conventional treatments in FDA-fast-tracked trials. FDA-approved cubosome technolog...
New herbal cubosome technology enhances arthritis treatment by improving bioavailability and targeting inflammation with fewer side effects than conventional drugs. Cutting-edge herbal cubosomes offer...
Recent studies show turmeric-based stains match conventional methods in oral cancer detection while reducing environmental impact, offering cost-effective solutions for low-resource settings. Turmeric...
Innovative cubosome delivery systems are transforming arthritis treatment by significantly improving the bioavailability and efficacy of herbal compounds like turmeric and boswellia. Breakthrough cubo...